Education & Research
Research, education, and practical guides on iboga, ibogaine, 5-MeO-DMT, and the integration of plant medicine experience.
Ibogaine and ketamine both show real results for treatment-resistant depression. They work through different mechanisms and serve different populations. The choice between them is not a matter of preference.
An iboga ceremony is not a psychedelic retreat in the wellness sense. The active experience runs 12–24 hours. The medicine tends to show people what they have been avoiding — not what they came to find.
An iboga retreat is not a weekend workshop. The active ceremony runs 12–24 hours. Recovery takes 2–3 days. The noribogaine that follows influences mood and craving for weeks. What you do with that window determines the outcome.
Ibogaine addresses depression and anxiety through mechanisms distinct from antidepressants. The 2023 Stanford study found 87% reductions in depression symptoms at one month — in a population where conventional treatment had not worked. Who this is for, and who it is not.
5-MeO-DMT and DMT share a chemical lineage. The experiences they produce are not comparable. Understanding the difference matters for anyone considering either medicine for depression, trauma, or addiction.
Ibogaine and psilocybin mushrooms are often named in the same conversation about psychedelic therapy. They operate through different mechanisms, serve different populations, and have different safety requirements. The choice between them is not a matter of preference.
Psychedelics in recovery is not a single treatment category. Ibogaine resets opioid receptor physiology in a way no other substance approaches. The distinctions between medicines — and between appropriate and inappropriate candidates — matter.
The active ibogaine experience runs 12–24 hours. Recovery takes 2–3 days. Noribogaine, the active metabolite, influences mood and craving for weeks to months — which is the part that determines whether any lasting change comes from it.
Iboga is the plant. Ibogaine is one alkaloid extracted from it. The choice between whole-plant preparations and isolated ibogaine is not just chemical — it is contextual, and it matters for what to expect from either.
Ibogaine is illegal in the United States because of a scheduling decision made in 1970 — not because of clinical evidence, which did not exist at the time. The research that now exists has not changed the schedule.
A bufo ceremony is 20–45 minutes of acute ego dissolution, a 2–3 day recovery period, and an integration process that determines whether anything lasting comes from it. It is not a gentle introduction to plant medicine.
Ibogaine and ayahuasca are often treated as interchangeable by people who have heard of both. They are not. The mechanisms are different, the experiences are different, and the conditions each addresses most effectively are different.
The cost of ibogaine treatment reflects something specific: the medical infrastructure required to administer it safely. Providers charging below market are not being generous — they are missing something. Understanding what that something is matters before the price does.
The most important factor when choosing an iboga retreat is not location, setting, or price. It is whether the provider has the medical infrastructure to keep you safe. Getting that wrong has killed people. Getting the setting wrong has not.
Ibogaine treatment works differently from anything else available for addiction, PTSD, and treatment-resistant depression. The research is no longer fringe. But it is not for everyone — and the cost of getting that wrong is too high to approach casually.
Opioid addiction is not a moral failing. It is a neurological condition driven by changes in the dopamine and opioid receptor systems. Ibogaine addresses this at the source — and the research is becoming impossible to ignore.
Before there was ibogaine — the isolated alkaloid studied in laboratories — there was iboga. A root bark. A tradition. A way of understanding the structure of a human life.
People often ask whether they should work with iboga or 5-MeO-DMT. The honest answer is that they are not substitutes for each other. They address different layers of the same problem.
In 2023, researchers at Stanford published a study that had the scientific community paying attention. Veterans with severe PTSD, traumatic brain injury, and treatment-resistant depression received ibogaine — and the results were striking.
The quality of your iboga experience is determined in large part before you arrive. This is not an exaggeration. Practitioners who have done this work for decades say the same thing: preparation is half the ceremony.
Many people make the mistake of treating the ceremony as the finish line. It is not. The ceremony opens a door. Integration is what you do with what you find on the other side.